This course is discontinued

Undervisningsplan

DatoUndervises avStedTemaKommentarer / ressurser
11.01.2010Jan Abel Olsen  12.15-15.00, Seminarrom 1, Harald Schjelderups hus   Introduction. Overview of the methodologies; CBA vs CEA. Efficiency; markets and market failures. Positive and normative issues.    
18.01.2010Jan Abel Olsen  12.15-15.00, Seminarrom 1, Harald Schjelderups hus   CEA/CUA – valuing benefits/ outcomes in health terms. QALYs    
25.01.2010Jan Abel Olsen  12.15-15.00, Seminarrom 1, Harald Schjelderups hus   CBA – valuing benefits/outcomes in money terms: WTP and production gains.    
01.02.2010Tor Iversen  12.15-15.00, Seminarrom 1, Harald Schjelderups hus   Cost concepts and costs in economic evaluation. Average, marginal and Incremental costs    
08.02.2010Tor Iversen  12.15-15.00, Seminarrom 1, Harald Schjelderups hus   Private vs social costs. Time costs Production losses.    
15.02.2010Tor Iversen  12.15-15.00, Seminarrom 1, Harald Schjelderups hus   Discounting costs and health effects.    
22.02.2010  12.15-15.00, Seminarrom 1, Harald Schjelderups hus   Applied CEA. Translating end-points used in clinical trials to CEA/CUA type units.    
01.03.2010  12.15-15.00, Aud 1, Harald Schjelderups hus   Modelling. From risk-reductions to increased life-time and/or improved health status Modelling II: computer exercise.    
08.03.2010Jan Abel Olsen  12.15-15.00, Seminarrom 1, Harald Schjelderups hus   Efficiency vs equity; fair distributions, priority setting The application of CEA and CBA in health policy; guidelines.    
22.03.2009  12.15-15.00, Seminarrom 1, Harald Schjelderups hus   Ekstraforelesning    
24.03.2010  09.15-12:00, Seminarrom 1, Harald Schjelderups hus   ICER, Sensitivity analyses, deterministic and probabilistic.    
16.04.2010  09.00-13.00, Seminarrom 1 and 4, Harald Schjelderups Hus  EXAM   
Published Nov. 24, 2009 10:30 AM - Last modified Mar. 16, 2010 5:26 PM